Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
Short Report
[키워드] ACE
ACE inhibitor
ACE inhibitors
ACE-2
ACEi
ACEIs
Activation
acute respiratory distress
acute respiratory distress syndrome
angiotensin
Angiotensin converting enzyme-2
angiotensin receptor antagonists
angiotensin receptor blocker
angiotensin-converting enzyme-1
angiotensin-converting enzyme-2
ARB
ARBs
ARDS
Arterial hypertension
cardiovascular
contribute
coronavirus
Coronavirus disease-19
COVID-19
COVID-19 patient
Discontinuing
Effect
implicated
Infection
medication
pathophysiology
pathway
Patient
plasma
Potential
Protective
RAAS
receptor
renal
renin-angiotensin-aldosterone system
respiratory
Respiratory failure
SARS
SARS- CoV-2
SARS-CoV-2
shown
syndrome
therapeutic
therapy
Treatment
virus
[DOI] 10.7554/eLife.57278 PMC 바로가기 [Article Type] Short Report
[DOI] 10.7554/eLife.57278 PMC 바로가기 [Article Type] Short Report